A quarter of the world carries it. Most will never know.
Tuberculosis is unusual among infections in that catching it and having the disease are two different things, often separated by decades. Most people who inhale Mycobacterium tuberculosis contain it. The bacilli survive inside granulomas, alive but dormant, doing nothing at all — until something weakens the immunity holding them there.
That single fact explains almost everything else about the topic: why a positive skin test is not a diagnosis, why HIV transformed the epidemiology of TB, why treatment takes six months rather than a week, and why interrupted treatment is not merely a failed course but the mechanism by which drug-resistant strains are made.
🩺 Where this lives: A patient starting an anti-TNF biologic for rheumatoid arthritis is screened for latent TB before the first dose — not because the drug causes tuberculosis, but because it dismantles the granuloma that has been holding a decades-old infection in check. The same logic applies before long-term corticosteroids and in newly diagnosed HIV. Screening asymptomatic people for an infection they do not know they have only makes sense once you understand latency.
The organism, and why it is difficult
MYCOBACTERIUM TUBERCULOSIS
ACID-FAST BACILLUS — a thick, waxy, mycolic-acid cell wall
→ resists standard Gram staining
→ needs Ziehl-Neelsen or auramine staining
→ resists drying and disinfectants
→ resists killing inside macrophages
SLOW GROWING — divides roughly every 15–20 hours
→ culture takes WEEKS, not days
→ and antibiotics that need dividing cells work slowly
→ which is a large part of why treatment lasts months
OBLIGATE AEROBE
→ thrives where oxygen tension is highest: the APICES
of the lungs. This is why reactivation disease
characteristically sits in the upper zones.
TRANSMISSION — airborne droplet nuclei from a person with
PULMONARY disease, coughing. Extrapulmonary TB is
generally NOT infectious, which surprises people.
Notice how many clinical facts fall out of two properties. The waxy wall explains the staining, the environmental hardiness and the intracellular survival. Slow division explains the long culture times and the long treatment. Being an obligate aerobe explains why reactivation TB is an upper-lobe disease — a radiological pattern you can derive rather than memorise.
What happens after exposure
Primary infection is usually asymptomatic. The bacilli are taken up by alveolar macrophages, the immune system mounts a cell-mediated response over several weeks, and granulomas form to wall them off. The classic Ghon focus — a subpleural lesion — with its draining hilar lymph nodes forms the Ghon complex, which may calcify and remain visible on a chest film for life.
🔍 Primary versus post-primary disease
PrimaryThe first encounter. Usually asymptomatic and self-limiting in an immunocompetent adult. In children and the immunosuppressed it may progress directly, and can disseminate — producing miliary TB or tuberculous meningitis.
Post-primary (reactivation)Dormant bacilli reactivate when immunity falls. Characteristically upper lobe, cavitating, and this is the classic infectious adult presentation.
Lifetime riskRoughly 5–10% of immunocompetent people with latent infection will reactivate at some point. In untreated HIV that risk rises to a similar figure per year — which is why HIV and TB are inseparable clinical problems.
Latent versus active — the distinction that governs everything
💡 Exam angle: a positive tuberculin skin test or IGRA proves infection, not disease. It tells you the immune system has met the organism; it cannot tell you whether that organism is currently contained or multiplying. So a positive test in an asymptomatic person with a normal chest film means latent infection, and the answer is preventive therapy — not a full treatment course. Questions test this by presenting a positive test and offering "start RIPE" as a plausible distractor.
How active TB presents
PULMONARY — about 80% of cases
Cough for more than 2–3 WEEKS — the cardinal symptom
Haemoptysis
Fever and DRENCHING NIGHT SWEATS
Weight loss and anorexia
Fatigue
The duration is what distinguishes it from ordinary
respiratory infection. A cough that has not resolved in
three weeks, in a setting where TB is common, deserves a
sputum sample rather than another antibiotic.
EXTRAPULMONARY — commoner in HIV and in children
Lymph node cervical, "scrofula" — the commonest
Pleural effusion
Spinal Pott disease — vertebral destruction,
may cause cord compression
Meningeal subacute, high mortality, a
neurological emergency
Abdominal · renal · pericardial · miliary (disseminated)
Diagnosis
🔍 The tests, and what each actually tells you
Sputum microscopyZiehl-Neelsen or auramine staining for acid-fast bacilli. Fast and cheap, but insensitive — it needs a high bacillary load, so a negative smear does not exclude TB.
Molecular testingNucleic acid amplification (such as Xpert MTB/RIF) detects the organism and rifampicin resistance within hours rather than weeks. This is the major practical advance in TB diagnosis and is now the recommended initial test in most settings.
CultureStill the reference standard, and the only way to get full drug susceptibility — but it takes weeks. You treat before it returns.
Chest X-rayUpper-lobe infiltrates and cavitation in reactivation disease; hilar lymphadenopathy in primary. Supportive, never diagnostic on its own.
Tuberculin skin test / IGRADetect the immune response to infection. Useful for latent TB. IGRA is unaffected by prior BCG vaccination, which is the main reason to prefer it where BCG is routine.
💡 Exam angle: two traps recur. A negative sputum smear does not exclude TB — smear sensitivity is limited, so a clinically compatible case with a negative smear still needs molecular testing and culture. And in advanced HIV, the classic picture breaks down: the chest film may be atypical or normal, cavitation is often absent because it requires an immune response to produce, and extrapulmonary and disseminated disease are far more common.
Treatment
The reason for four drugs is worth stating precisely, because it is the intellectual core of TB therapy. Spontaneous mutations conferring resistance to any single drug arise naturally within a large bacillary population. Treat with one drug and you simply select for those mutants. The probability that a single organism carries resistance to four unrelated drugs simultaneously is vanishingly small — so combination therapy is not about additive potency, it is about denying resistance a foothold. Every shortcut in adherence reopens that door.
MONITORING AND SPECIAL SITUATIONS
BASELINE liver function, visual acuity and colour
vision (before ethambutol), HIV test
DURING symptoms of hepatitis; repeat LFTs if
symptomatic; monthly clinical review
PYRIDOXINE given with isoniazid to prevent
peripheral neuropathy — routine in
malnutrition, pregnancy, alcohol
dependence, diabetes, HIV and CKD
HIV CO-INFECTION treat TB, and start antiretrovirals —
but beware IMMUNE RECONSTITUTION
INFLAMMATORY SYNDROME, where symptoms
paradoxically worsen as immunity
recovers. It is not treatment failure.
DRUG-RESISTANT TB
MDR-TB resistant to at least isoniazid AND rifampicin
XDR-TB MDR plus resistance to further key agents
Both need specialist regimens, longer treatment and
are far harder to cure — the direct consequence of
incomplete treatment somewhere upstream.
Clinical reasoning: four presentations
🔍 Case 1 — the positive test
PresentationA 30-year-old nurse has a positive IGRA on occupational screening. She is completely well, with no cough or weight loss. Chest X-ray is normal.
The distractorA positive TB test invites a full treatment course.
ReasoningThe test shows infection, not disease. Asymptomatic, normal film, no bacteriological evidence — this is latent TB. She is neither ill nor infectious.
AnswerExclude active disease, then offer preventive therapy for latent infection. A full multi-drug regimen would be over-treatment.
🔍 Case 2 — the colour that gives it away
PresentationA patient two weeks into TB treatment returns alarmed that his urine and tears have turned orange. He feels well and has no jaundice.
ReasoningRifampicin colours body fluids orange-red. It is harmless and expected — but if nobody warned him, it looks like a serious drug reaction and is a common reason patients stop treatment on their own.
AnswerReassure and continue. Counselling about this at the start is part of protecting adherence — and adherence is what prevents resistance. Note the separate point: rifampicin is a potent enzyme inducer, so a woman on the combined pill needs alternative contraception.
🔍 Case 3 — the visual complaint
PresentationSix weeks into RIPE therapy, a patient reports that colours look washed out and his vision is blurred.
Key clueLoss of colour discrimination with reduced acuity points to the optic nerve.
ReasoningEthambutol causes dose-related optic neuritis, classically affecting red–green discrimination first. It is usually reversible if the drug is stopped promptly, and can be permanent if it is not.
AnswerStop ethambutol and refer for ophthalmological assessment, continuing the other agents under specialist advice. "E for Eyes" is the memory hook, and the urgency is the real teaching point.
🔍 Case 4 — worse before better
PresentationA patient with HIV and TB starts antiretroviral therapy three weeks into TB treatment. Two weeks later his fever returns and his lymph nodes enlarge. TB cultures show a good response.
TrapDeterioration looks like treatment failure or resistance.
ReasoningImmune reconstitution inflammatory syndrome: as antiretrovirals restore immune function, the recovering immune system mounts a vigorous inflammatory response to residual mycobacterial antigen. The paradox is that it signals immunity returning.
AnswerRecognise IRIS. Continue both TB treatment and antiretrovirals; manage the inflammation, with corticosteroids in severe cases and specialist input. Stopping treatment here would be exactly wrong.
Commonly confused
Confusion
The distinction
Why it matters
Latent vs active TB
Latent is asymptomatic, non-infectious, normal film
Preventive therapy versus a full multi-drug course.
Positive IGRA vs active disease
The test shows infection, not disease
Treating latent infection as active is over-treatment.
Negative smear vs no TB
Smear needs a high bacillary load
A negative smear never excludes TB clinically.
Primary vs post-primary
Primary is often hilar and lower/mid zone; reactivation is upper lobe and cavitating
The apical pattern follows from the organism being an obligate aerobe.
IRIS vs treatment failure
IRIS worsens as immunity recovers, with a good bacteriological response
Stopping treatment for IRIS would be the wrong response.
MUST-KNOW FACTS
1. M. tuberculosis is an acid-fast bacillus — Ziehl-Neelsen staining.
2. The waxy mycolic-acid wall explains staining, hardiness and intracellular survival.
3. Slow division → culture takes WEEKS and treatment takes MONTHS.
4. Obligate aerobe → reactivation disease favours the lung APICES.
5. Spread by airborne droplet nuclei from pulmonary disease.
6. Extrapulmonary TB is generally NOT infectious.
7. Ghon focus + hilar nodes = Ghon complex (primary infection).
8. Latent TB: asymptomatic, non-infectious, normal chest film, positive IGRA.
9. A positive skin test or IGRA proves INFECTION, not disease.
10. Lifetime reactivation risk ~5–10%; far higher, and per-year, in HIV.
11. HIV is the strongest risk factor for progression to active disease.
12. Cardinal symptom: cough for more than 2–3 weeks, with night sweats and weight loss.
13. A negative sputum smear does NOT exclude TB.
14. Xpert MTB/RIF gives a result in hours and detects rifampicin resistance.
15. Culture remains the reference standard for full susceptibility.
16. IGRA is unaffected by prior BCG vaccination.
17. RIPE for 2 months, then RI for 4 months.
18. Rifampicin: orange fluids, hepatitis, potent CYP450 INDUCER.
19. Isoniazid: peripheral neuropathy — give pyridoxine.
20. Pyrazinamide: hyperuricaemia and gout; most hepatotoxic.
21. Ethambutol: optic neuritis — "E for Eyes".
22. Four drugs are used to deny resistance a foothold, not for extra potency.
23. Interrupted treatment is how MDR-TB is created.
24. MDR-TB = resistant to at least isoniazid AND rifampicin.
25. IRIS: paradoxical worsening as immunity recovers — not treatment failure.
💡 Exam angle: the reliable threads are (a) latent versus active and what a positive test actually means, (b) which drug causes which toxicity, (c) why combination therapy prevents resistance, (d) IRIS in HIV co-infection, and (e) a negative smear failing to exclude disease. Almost all of them are cases where a test result or a symptom means something narrower than it first appears — which is the habit this chapter is trying to build.
Syllabus points
The organism: acid-fast, slow-growing, obligate aerobe
Transmission and infectivity
The three outcomes after inhalation
Primary infection and the Ghon complex
Latent infection and what reactivates it
Latent versus active disease
Pulmonary and extrapulmonary presentations
Diagnostic tests and what each proves
The four first-line drugs and their toxicities
The regimen, and why four drugs prevent resistance
HIV co-infection and IRIS
Drug-resistant tuberculosis
Create a free account to tick topics off, take notes as you read, watch the video lessons and get a day-by-day study plan built around your exam date.